Factors associated with HIV-infected women's use or intention to use AZT during pregnancy

AIDS Education and Prevention

Volumn 13, Issue 3, 2001, Pages 189-206

  Siegel, K ^a   Lekas, H M ^a   Schrimshaw, E W ^a   Johnson, J K ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ATTITUDE; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG USE; EXPERIENCE; FEAR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLNESS BEHAVIOR; INTERVIEW; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; PATIENT EDUCATION; PREGNANCY; TERATOGENICITY; UNITED STATES; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADULT; ANTIVIRAL AGENTS; ATTITUDE; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INTERVIEWS; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; SAMPLING STUDIES; ZIDOVUDINE;

EID: 0034945538     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.13.3.189.19747     Document Type: Article

References (25)

1. Reproductive decisions of women at risk for acquiring HIV infection
2. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel project for the prevention of HIV transmission from mother to infant
3. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States
4. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment
5. Maternal free-cell veremia in the natural history of perinatal human immunodeficiency virus transmission: A meta-analysis
6. Lack of long-term effects of in uteri exposure to zidovudine among uninfected children born to HIV-infected women
7. AIDS in blackface
8. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties
9. Effects of ZDV-based patient education on intentions toward ZDV use, HIV testing and reproduction among a US cohort of women
10. Review of uptake of interventions to reduce mother to child transmission of HIV by women aware of their HIV status
11. HIV-infected women's decisions to take antiretrovirals
12. Zidovudine adherence among individuals with HIV infection
13. Reproductive decisions among HIV-infected, drug-using women: The importance of mother-child coresidence
14. HIV-infected women: Barriers to AZT use
15. Racial differences in attitudes toward protease inhibitors among older HIV-infected men
16. Reasons and justifications for considering pregnancy among women living with HIV/AIDS
17. Symptom interpretation and medication adherence among late middle-age and older HIV-infected adults
18. Accounts for non-adherence to antiviral combination therapies among older HIV-infected adults
19. Zidovudine adherence in persons with AIDS: The relation of patient beliefs about medication to self-termination of therapy
20. Health care providers' influence on HIV-infected women's beliefs and intentions related to AZT therapy
21. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
22. The impact of human immunodeficiency virus serostatus on reproductive decisions of women
23. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center